Opendata, web and dolomites

ClarifyLupus

Launching the Breakthrough in Lupus Diagnostics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ClarifyLupus project word cloud

Explore the words cloud of the ClarifyLupus project. It provides you a very rough idea of what is the project "ClarifyLupus" about.

diagnostic    team    patients    analytical    lupus    6m    passed    founded    disease    damages    market    rule    rodrigues    prestigious    altered    portuguese    methodology    competitors    autoimmune    decades    perform    stating    stage    blood    technologists    clarifylupus    atilde    start    egas    hospital    moniz    acceleration    letter    diagnosis    jo    clinical    diseases    tested    autoantibodies    approval    2017    cohitech    devastating    25m    usa    irreversible    members    recruiting    worse    symptoms    alexandra    business    13    antunes    diagnosed    biomarker    occurrence    assays    difficulty    2018    expert    onset    april    quality    stages    disruption    secured    proof    clarify    committee    breakthrough    unspecific    lab    samples    ethical    january    mass    alone    proteins    discovery    spectroscopy    people    conducting    later    confirm    lisbon    until    overlapping    confounding    play    diagnosing    portugal    8m    unavailability    toxicology    lives    quantifying    earlier    contrast   

Project "ClarifyLupus" data sheet

The following table provides information about the project.

Coordinator
CLARIFY ANALYTICAL LDA 

Organization address
address: RUA DE MERCADORES 128A
city: EVORA
postcode: 7000-872
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://www.clarifyanalytical.pt/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CLARIFY ANALYTICAL LDA PT (EVORA) coordinator 50˙000.00

Map

 Project objective

The difficulty on diagnosing lupus is due not only to the occurrence of overlapping symptoms with other autoimmune diseases but also to the unavailability of a lab test to confirm or rule out Lupus. The autoimmune disease is devastating, and the later it is diagnosed, the worse are the irreversible damages to the patients. In the USA alone, there are 13.8M people with Lupus and overlapping diseases and 2,6M new cases of these diseases are diagnosed each year. These diseases affect more than 25M people in the EU. We have developed a technology capable of identifying and quantifying altered proteins that play a key role in the onset of Lupus. Our product ClarifyLupus is a diagnostic test that is effective since the early stages of the disease. Although our competitors are conducting research on Lupus biomarker discovery, they all are focused in autoantibodies biomarker discovery that are highly unspecific among Lupus-confounding diseases. In contrast we have a Lupus-specific biomarker that enables the Lupus diagnosis much earlier than our competitors. We have passed the proof-of-concept stage where our diagnosis methodology was tested in blood samples and in January 2018 we have secured the Portuguese ethical committee approval to perform clinical assays, and are recruiting 50 patients until the end of the year. In April 2018 we secured a Letter of Support from the Egas Moniz Hospital in Lisbon, stating the importance and market disruption of ClarifyLupus. Clarify Analytical was founded in 2017 by Alexandra Antunes and João Rodrigues, two expert technologists in the fields of toxicology and mass spectroscopy, supported by 3 team members. The start-up was selected for the prestigious CoHiTech acceleration program in Portugal, focused on business and technology go-to-market. ClarifyLupus will be the breakthrough for Lupus diagnosis which will allow Lupus patients to be treated earlier, extending their lives by decades and improving their quality.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLARIFYLUPUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLARIFYLUPUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

PAROST (2019)

Disruptive technology for the identification, quantification and prediction of the evolution of damages in civil engineering structures that increases safety while reducing maintenance costs.

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More